Stanford Bone Marrow Transplant and Cellular Therapy Center
BMT Core - Stanford University
['FUNDING_OTHER'] · STANFORD UNIVERSITY · NIH-11166434
This program runs clinical trials of bone marrow and cellular transplants for adults who need autologous or allogeneic transplants, including therapies to prevent or treat acute graft-versus-host disease.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | STANFORD UNIVERSITY (nih funded) |
| Locations | 1 site (STANFORD, UNITED STATES) |
| Trial ID | NIH-11166434 on ClinicalTrials.gov |
What this research studies
Stanford is applying to continue as a core center that runs and coordinates national clinical trials in bone marrow and cellular transplantation. If you're a patient, that means you could be offered chances to join studies using matched or mismatched donor cells, cord blood, gene-modified cell products, and CAR-T therapies. The center treats hundreds of adults each year and has a certified cell-processing facility and experienced research and data teams to run trials safely. Being part of this network gives patients access to new transplant options and research-focused care.
Who could benefit from this research
Good fit: Ideal candidates are adults (21+ years) undergoing or being considered for autologous or allogeneic bone marrow/cellular transplantation, including those at risk for or with acute GVHD.
Not a fit: This program is focused on adult transplant patients and may not benefit children, people not undergoing transplant, or those who are ineligible for clinical trials at Stanford.
Why it matters
Potential benefit: If funded, this will help keep open access to cutting-edge transplant and cellular therapy trials that may improve survival and reduce complications like acute graft-versus-host disease.
How similar studies have performed: Related clinical trials and prior BMT CTN studies have shown meaningful advances in transplant outcomes and cellular therapies, and Stanford has previously enrolled many patients in successful trials.
Where this research is happening
STANFORD, UNITED STATES
- STANFORD UNIVERSITY — STANFORD, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MUFFLY, LORI — STANFORD UNIVERSITY
- Study coordinator: MUFFLY, LORI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acute Graft Versus Host Disease